US equities
|
MU
$1,072.75
▼-1.40%
NVDA
$235.39
▼-0.88%
SNDK
$1,644.00
▼-2.86%
PLTR
$198.05
▲+2.02%
AMD
$633.64
▼-1.89%
INTC
$109.50
▼-3.20%
SPCX
$163.53
▼-2.43%
META
$719.50
▼-0.25%
MU
$1,072.75
▼-1.40%
NVDA
$235.39
▼-0.88%
SNDK
$1,644.00
▼-2.86%
PLTR
$198.05
▲+2.02%
AMD
$633.64
▼-1.89%
INTC
$109.50
▼-3.20%
SPCX
$163.53
▼-2.43%
META
$719.50
▼-0.25%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Biocorrx Inc
(OP:
BICX
)
0.2010
UNCHANGED
Delayed Quote
Updated: 11:20 AM EDT, Oct 7, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biocorrx Inc
< Previous
1
2
3
Next >
BioCorRx Begins Recruitment for Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder
April 27, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
BioCorRx to Present at the Planet MicroCap Showcase 2022 in Las Vegas on May 4th
April 26, 2022
ANAHEIM, CA / ACCESSWIRE / April 26, 2022 / BioCorRx Inc. (OTCQB:BICX) (the "Company"), a developer and provider of innovative treatment programs fr substance abuse and related disorders, today...
From
BioCorRx Inc.
Via
AccessWire
BioCorRX Inc. Discusses FDA Approval Process for Implantable Naltrexone Pellet, BICX104, with The Stock Day Podcast
April 19, 2022
Phoenix, Arizona--(Newsfile Corp. - April 19, 2022) - The Stock Day Podcast welcomed BioCorRx Inc. (OTCQB: BICX) ("the Company"), an...
Via
Newsfile
BioCorRx Announces Additional Award of Nearly $100,000 from NIDA for BICX104, its Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder
April 11, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
BioCorRx Provides 2021 Year-End Business Update
April 01, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
BioCorRx to Participate in Two Upcoming Conferences
March 22, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
BioCorRx Announces IRB Approval to Begin Phase I Clinical Trial of BICX104, an Implantable Biodegradable Naltrexone Pellet for the Treatment of Opioid Use Disorder
March 16, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
BioCorRx Announces Orange County Research Center as Clinical Trial Site for First-In-Human Clinical Trial of BICX104
February 14, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
BioCorRx to Present at the H.C. Wainwright BioConnect 2022 Conference
January 05, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
BioCorRx Appoints Drug Delivery Expert Jie Shen, Ph.D., to Scientific Advisory Board
December 09, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
BioCorRx to Participate in the Benzinga All Access Event on December 2nd
November 24, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
BioCorRx Acquires Intellectual Property for Drug Delivery
November 22, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Intellectual Property
BioCorRx Provides Business Update for the Third Quarter of 2021
November 16, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Intellectual Property
2 Penny Stocks Insiders Are Buying
↗
October 26, 2021
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider...
Via
Benzinga
BioCorRx Files Patent Application with the Russian Patent Office (Rospatent) for Naltrexone Implant
October 07, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Intellectual Property
BioCorRx Inc. (BICX) Featured in Virtual Coverage of LD Micro’s Main Event
October 01, 2021
Via
Investor Brand Network
BioCorRx to Present at LD Micro Main Event on Tuesday, October 12th
September 29, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
BioCorRx Files Patent Application with USPTO for Naltrexone Implant
September 22, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Intellectual Property
Recro and BioCorRx Expand Development and Manufacturing Relationship to Support BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder
September 08, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
BioCorRx Announces Award of Approximately $3.5 Million NIDA Grant for the Clinical Trial of BICX104, its Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder
September 01, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
BioCorRx Provides Business Update for the Second Quarter of 2021
August 16, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
BioCorRx Welcomes Four Experts to Expanded Scientific Advisory Board
June 22, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
BioCorRx Provides Business Update for the First Quarter of 2021
May 18, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
BioCorRx Receives FDA Clearance of Investigational New Drug (IND) Application for BICX104, its Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder
May 10, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Death
BioCorRx Announces Submission of IND Application to the FDA for BICX104, Implantable Naltrexone
April 13, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Death
< Previous
1
2
3
Next >
